NET PROFIT (x1000 DKK)
EMPLOYEES
Signum Life Science ApS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-2,853
|
-13,403
|
2,787 |
Total assets |
131,454
|
133,491
|
150,970 |
Current assets |
53,279
|
55,609
|
69,001 |
Current liabilities |
13,415
|
12,168
|
15,232 |
Equity capital |
112,748
|
115,832
|
128,463 |
- share capital |
75
![]() |
75
![]() |
75 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
85.8%
|
86.8%
|
85.1% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
397.2%
|
457.0%
|
453.0% |
Return on equity (ROE) |
-2.5%
|
-11.6%
|
2.2% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.